All Relations between cannabis and cannabinoids

Publication Sentence Publish Date Extraction Date Species
Tenghan Ling, Aiping Yin, Yan Cao, Jiali Li, Hengxi Li, Ying Zhou, Xiaobing Guo, Jinghui Li, Ruilin Zhang, Haiying Wu, Ping L. Purinergic astrocyte signaling driven by TNF-α after cannabidiol administration restores normal synaptic remodeling following traumatic brain injury. Neuroscience. 2024-03-09. PMID:38460903. cannabidiol (cbd), a primary derivative from plant-based cannabinoids, exhibits a range of beneficial effects, including analgesic, sedative, anti-inflammatory, anticonvulsant, anti-anxiety, anti-apoptotic, and neuroprotective properties. 2024-03-09 2024-03-12 Not clear
Mona M Geweda, Chandrani G Majumdar, Malorie N Moore, Mostafa A Elhendawy, Mohamed M Radwan, Suman Chandra, Mahmoud A ElSohl. Evaluation of dispensaries' cannabis flowers for accuracy of labeling of cannabinoids content. Journal of cannabis research. vol 6. issue 1. 2024-03-09. PMID:38461280. evaluation of dispensaries' cannabis flowers for accuracy of labeling of cannabinoids content. 2024-03-09 2024-03-12 human
Anna C Love, Trevor N Purdy, Felix M Hubert, Ella J Kirwan, Darren C Holland, Bradley S Moor. Discovery of Latent Cannabichromene Cyclase Activity in Marine Bacterial Flavoenzymes. ACS synthetic biology. 2024-03-09. PMID:38459634. production of phytocannabinoids remains an area of active scientific interest due to the growing use of cannabis by the public and the underexplored therapeutic potential of the over 100 minor cannabinoids. 2024-03-09 2024-03-11 Not clear
Morgan L Ferretti, Taylor B Stanley, Erica N Peters, Marcel O Bonn-Miller, Jessica G Iron. Examination of the effects of cannabidiol on menstrual-related symptoms. Experimental and clinical psychopharmacology. 2024-03-07. PMID:38451730. some individuals attempt to alleviate menstrual-related symptoms (mrs) by using cannabis and report having expectations that cannabis can improve mrs; however, no study has examined the effect of cannabinoids on mrs. 2024-03-07 2024-03-10 human
Christopher Humphries, Marianne Gilling. RCEM best practice guideline: suspected cannabinoid hyperemesis syndrome in emergency departments. Emergency medicine journal : EMJ. 2024-03-06. PMID:38448215. cannabinoid hyperemesis syndrome (chs) is an episodic syndrome of cyclic vomiting in the context of the prolonged use of cannabis. 2024-03-06 2024-03-09 Not clear
Michelle Goulette, Nicolas J Schlienz, Amy A Case, Eric Hansen, Cheryl Rivard, Rebecca L Ashare, Maciej L Goniewicz, Maansi Bansal-Travers, Andrew Hyland, Danielle M Smit. Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. vol 32. issue 4. 2024-03-05. PMID:38443674. this study aimed to examine knowledge of thc or cbd concentration among patients living with cancer who consume cannabis, and factors associated with knowledge of cannabinoid concentrations. 2024-03-05 2024-03-08 Not clear
Melody Cui Sun, Almudena Otálora-Alcaraz, Jack A Prenderville, Eric J Downe. Toll-like receptor signalling as a cannabinoid target. Biochemical pharmacology. 2024-03-04. PMID:38438052. cannabinoids include component of the plant cannabis sativa l. (c. sativa), synthetic and endogenous ligands, and overall represent a class of compounds whose therapeutic potential and mechanism of action continues to be elucidated. 2024-03-04 2024-03-07 Not clear
Avanti Puri, Filippo Costanzo, Janny Rivera, Jean Bujdo. Catatonia Induced by First-Time Use of Synthetic Cannabinoids: A Case Report. Cureus. vol 16. issue 1. 2024-03-04. PMID:38435863. in this case report, we present one of the first cases of catatonia induced by first-time synthetic cannabinoids with no previous history of cannabis use disorder. 2024-03-04 2024-03-06 Not clear
Irma Castro-Navarro, Mark A McGuire, Janet E Williams, Elizabeth A Holdsworth, Courtney L Meehan, Michelle K McGuir. Maternal cannabis use during lactation and potential effects on human milk composition and production: a narrative review. Advances in nutrition (Bethesda, Md.). 2024-03-03. PMID:38432590. several studies have demonstrated that cannabinoids and their metabolites are detectable in human milk produced by mothers who use cannabis. 2024-03-03 2024-03-06 human
Anjali K Bhardwaj, Llew Mills, Michael Doyle, Arshman Sahid, Mark Montebello, Lauren Monds, Shalini Arunogiri, Paul Haber, Valentina Lorenzetti, Dan I Lubman, Peter Malouf, Mary E Harrod, Adrian Dunlop, Tom Freeman, Nicholas Lintzeri. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. BMC psychiatry. vol 24. issue 1. 2024-03-03. PMID:38433233. cannabidiol (cbd) is a non-intoxicating cannabinoid recognised for its anticonvulsant, anxiolytic and antipsychotic effects with no habit-forming qualities. 2024-03-03 2024-03-06 Not clear
Sabrina Bimonte, Davide Nocerino, Daniela Schiavo, Marco Crisci, Marco Cascella, Arturo Cuom. Cannabinoids for Cancer-related Pain Management: An Update on Therapeutic Applications and Future Perspectives. Anticancer research. vol 44. issue 3. 2024-02-29. PMID:38423660. unfortunately, opioid treatment causes side effects and inefficiently relieves patients from pain, therefore alternative therapies have been considered, including cannabis sativa and cannabinoids. 2024-02-29 2024-03-03 Not clear
Sabrina Bimonte, Davide Nocerino, Daniela Schiavo, Marco Crisci, Marco Cascella, Arturo Cuom. Cannabinoids for Cancer-related Pain Management: An Update on Therapeutic Applications and Future Perspectives. Anticancer research. vol 44. issue 3. 2024-02-29. PMID:38423660. accumulating evidence has highlighted that an increasing number of patients are choosing to use cannabis and cannabinoids for the management of their soothing and non-palliative cancer pain and other cancer-related symptoms. 2024-02-29 2024-03-03 Not clear
Radhika Anand, Ritu Painuli, Vijay Kumar, Parvinder Pal Sing. Chemistry and pharmacological aspects of furanoid cannabinoids and related compounds: Is furanoid cannabinoids open a new dimension towards the non-psychoactive cannabinoids? European journal of medicinal chemistry. vol 268. 2024-02-28. PMID:38417219. cannabinoids have emerged as compelling candidates for medicinal applications, notably following the recent approval of non-psychoactive cannabidiol (cbd) as a medicine. 2024-02-28 2024-03-02 human
Jenny L Wiley, Julie A Marusich, Bruce E Blough, Ojas Namjoshi, Marcus Brackeen, Luli R Akinfiresoye, Teneille D Walker, Cassandra Prioleau, Daniel G Barrus, Thomas F Gamag. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice. Progress in neuro-psychopharmacology & biological psychiatry. 2024-02-28. PMID:38417478. the cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. 2024-02-28 2024-03-02 mouse
J J Rosado-Franco, A L Ellison, C J White, A S Price, C F Moore, R E Williams, L B Fridman, E M Weerts, D W William. Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models. Physiological reports. vol 12. issue 4. 2024-02-28. PMID:38408761. increasing interest in the endocannabinoid system has arisen due to these physiologic roles, policy changes leading to more widespread recreational use, and the therapeutic potential of cannabis and phytocannabinoids. 2024-02-28 2024-03-01 mouse
Michael W Degregorio, Chiao-Jung Kao, Gregory T Wur. Complexity of Translating Analytics to Recent Cannabis Use and Impairment. Journal of AOAC International. 2024-02-27. PMID:38410076. a new testing approach has been developed based on exhaled breath and blood sampling that incorporates kinetic changes and the presence of key cannabinoids to detect recent cannabis use within the impairment window without the false positive results seen with other methods. 2024-02-27 2024-03-02 human
Amy L Cherry, Michael J Wheeler, Karolina Mathisova, Mathieu Di Micel. Frontiers in neuroinformatics. vol 18. 2024-02-26. PMID:38404644. the endocannabinoid (ecb) system is named after the discovery that endogenous cannabinoids bind to the same receptors as the phytochemical compounds found in cannabis. 2024-02-26 2024-02-28 Not clear
Amy L Cherry, Michael J Wheeler, Karolina Mathisova, Mathieu Di Micel. Frontiers in neuroinformatics. vol 18. 2024-02-26. PMID:38404644. while endogenous cannabinoids include anandamide (aea) and 2-arachidonoylglycerol (2-ag), exogenous phytocannabinoids include Δ-9 tetrahydrocannabinol (thc) and cannabidiol (cbd). 2024-02-26 2024-02-28 Not clear
Emese Kroon, Janna Cousijn, Francesca Filbey, Christian Berchtold, Tina M Binz, Lauren Kuhn. Associations between hair-derived cannabinoid levels, self-reported use, and cannabis-related problems. Psychopharmacology. 2024-02-26. PMID:38407636. as cannabis potency and cannabis use are increasing in newly legalized markets, it is increasingly important to measure and examine the effects of cannabinoid exposure. 2024-02-26 2024-02-28 Not clear
Luana Barreto Domingos, Heidi Kaastrup Müller, Nicole Rodrigues da Silva, Michaela D Filiou, Anders Lade Nielsen, Francisco Silveira Guimarães, Gregers Wegener, Sâmia Joc. Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression. Neuropharmacology. 2024-02-24. PMID:38401791. repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the flinders sensitive line (fsl) rat model of depression. 2024-02-24 2024-02-27 rat